Procter & Gamble (NYSE:PG) Receives New Coverage from Analysts at Piper Sandler

Investment analysts at Piper Sandler started coverage on shares of Procter & Gamble (NYSE:PGGet Free Report) in a note issued to investors on Tuesday, Briefing.com reports. The brokerage set a “neutral” rating and a $174.00 price target on the stock. Piper Sandler’s price target suggests a potential upside of 0.13% from the stock’s current price.

Other equities analysts have also recently issued research reports about the company. JPMorgan Chase & Co. lifted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Stifel Nicolaus upped their price target on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a report on Monday, July 22nd. Jefferies Financial Group lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $182.00 to $175.00 in a report on Wednesday, July 24th. Dbs Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, TD Cowen initiated coverage on Procter & Gamble in a report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 target price for the company. Eight equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $175.89.

Check Out Our Latest Research Report on PG

Procter & Gamble Price Performance

Shares of PG stock opened at $173.77 on Tuesday. The stock has a 50-day moving average price of $170.40 and a 200 day moving average price of $165.88. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The firm has a market cap of $410.12 billion, a price-to-earnings ratio of 28.39, a PEG ratio of 3.84 and a beta of 0.41. Procter & Gamble has a 12 month low of $141.45 and a 12 month high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The business had revenue of $20.53 billion during the quarter, compared to analysts’ expectations of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm’s quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.37 EPS. Research analysts expect that Procter & Gamble will post 6.97 EPS for the current year.

Insider Activity

In other Procter & Gamble news, CEO R. Alexandra Keith sold 3,373 shares of the business’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now owns 21,513 shares of the company’s stock, valued at $3,657,210. The sale was disclosed in a document filed with the SEC, which is available through this link. In related news, CEO Jon R. Moeller sold 37,240 shares of Procter & Gamble stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the sale, the chief executive officer now owns 263,537 shares of the company’s stock, valued at approximately $44,508,763.93. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R. Alexandra Keith sold 3,373 shares of the stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $170.00, for a total transaction of $573,410.00. Following the completion of the transaction, the chief executive officer now directly owns 21,513 shares in the company, valued at $3,657,210. The disclosure for this sale can be found here. Insiders sold a total of 375,553 shares of company stock valued at $63,829,141 in the last quarter. Company insiders own 0.17% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

A number of large investors have recently made changes to their positions in PG. Itau Unibanco Holding S.A. bought a new stake in Procter & Gamble in the 2nd quarter valued at about $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble in the second quarter valued at approximately $29,000. Ruedi Wealth Management Inc. grew its position in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares in the last quarter. POM Investment Strategies LLC bought a new position in Procter & Gamble during the 2nd quarter worth $34,000. Finally, Transcendent Capital Group LLC acquired a new position in Procter & Gamble in the 4th quarter valued at $31,000. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Company Profile

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.